Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thanh C Ho

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Organic Letters|August 30, 2016
Total Synthesis of (+)-Vicenin-2Thanh C Ho, Haruki Kamimura, Ken Ohmori, et al.
Drug and Alcohol Dependence|October 3, 2022
Effects of the cannabinoid CB<sub>1</sub>-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male ratsDalal AlKhelb, Andre Kirunda, Thanh C Ho, et al.
The Journal of Organic Chemistry|July 6, 2017
C1'-Azacycloalkyl HexahydrocannabinolsThanh C Ho, Naoyuki Shimada, Marcus A Tius, et al.
Molecules (Basel, Switzerland)|October 5, 2019
Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid ReceptorShakiru O Alapafuja, Spyros P Nikas, Thanh C Ho, et al.
International Journal of Molecular Sciences|January 8, 2023
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic RatsDimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, et al.
Molecules (Basel, Switzerland)|February 12, 2020
Synthesis of Functionalized CannabilactonesYingpeng Liu, Thanh C Ho, Mohammed Baradwan, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2021
Oxa-adamantyl cannabinoidsThanh C Ho, Marcus A Tius, Spyros P Nikas, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2022
Corrigendum to "Oxa-adamantyl cannabinoids" [Bioorg. Med. Chem. Lett. 38 (2021) 127882]Thanh C Ho, Joseph J Mullins, Marcus A Tius, et al.
European Journal of Pharmacology|December 7, 2023
Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201Dalal AlKhelb, Emily L Burke, Alexander Zvonok, et al.
Nature Communications|March 5, 2025
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Organic Letters|August 30, 2016
Total Synthesis of (+)-Vicenin-2Thanh C Ho, Haruki Kamimura, Ken Ohmori, et al.
Drug and Alcohol Dependence|October 3, 2022
Effects of the cannabinoid CB<sub>1</sub>-receptor neutral antagonist AM4113 and antagonist/inverse agonist rimonabant on fentanyl discrimination in male ratsDalal AlKhelb, Andre Kirunda, Thanh C Ho, et al.
The Journal of Organic Chemistry|July 6, 2017
C1'-Azacycloalkyl HexahydrocannabinolsThanh C Ho, Naoyuki Shimada, Marcus A Tius, et al.
Molecules (Basel, Switzerland)|October 5, 2019
Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid ReceptorShakiru O Alapafuja, Spyros P Nikas, Thanh C Ho, et al.
International Journal of Molecular Sciences|January 8, 2023
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic RatsDimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, et al.
Molecules (Basel, Switzerland)|February 12, 2020
Synthesis of Functionalized CannabilactonesYingpeng Liu, Thanh C Ho, Mohammed Baradwan, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2021
Oxa-adamantyl cannabinoidsThanh C Ho, Marcus A Tius, Spyros P Nikas, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2022
Corrigendum to "Oxa-adamantyl cannabinoids" [Bioorg. Med. Chem. Lett. 38 (2021) 127882]Thanh C Ho, Joseph J Mullins, Marcus A Tius, et al.
European Journal of Pharmacology|December 7, 2023
Effects of cannabinoid agonists and antagonists in male rats discriminating the synthetic cannabinoid AM2201Dalal AlKhelb, Emily L Burke, Alexander Zvonok, et al.
Nature Communications|March 5, 2025
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Pageof 2